|
Thrombolysis
Citations 531-540 of 839 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Using Mismatch on MRI to Select Thrombolytic Responders. An Attractive Hypothesis Awaiting Confirmation
- Stephen M. Davis and Geoffrey A. Donnan
Stroke published March 31, 2005, doi:10.1161/01.STR.0000162390.53046.4b
[Abstract]
- Articles
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours. Con
- Justin A. Zivin
Stroke published March 24, 2005, doi:10.1161/01.STR.0000162389.44928.de
[Abstract]
- Articles
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours. Pro
- Peter D. Schellinger and Jochen B. Fiebach
Stroke published March 24, 2005, doi:10.1161/01.STR.0000162388.67745.8d
[Abstract]
- Articles
Early Recanalization Rates and Clinical Outcomes in Patients With Tandem Internal Carotid Artery/Middle Cerebral Artery Occlusion and Isolated Middle Cerebral Artery Occlusion
- Yo Sik Kim, Zsolt Garami, Robert Mikulik, Carlos A. Molina, Andrei V. Alexandrov for the CLOTBUST Collaborators
Stroke published March 3, 2005, doi:10.1161/01.STR.0000160007.57787.4c
[Abstract]
- Articles
Markedly Reduced Apparent Blood Volume on Bolus Contrast Magnetic Resonance Imaging as a Predictor of Hemorrhage After Thrombolytic Therapy for Acute Ischemic Stroke
- David C. Alsop, Elena Makovetskaya, Sandeep Kumar, Magdy Selim, and Gottfried Schlaug
Stroke published March 3, 2005, doi:10.1161/01.STR.0000158913.91058.93
[Abstract]
- Original Contributions
Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
- Marc Ribo, Carlos A. Molina, Alex Rovira, Manuel Quintana, Pilar Delgado, Joan Montaner, Elisenda Grivé, Juan F. Arenillas, and José Álvarez-Sabín
Stroke 2005;36:602-606; published online before print as doi:10.1161/01.STR.0000155737.43566.ad
[Abstract]
[Full text]
- Original Contributions
A Pilot Dose-Escalation Safety Study of Tenecteplase in Acute Ischemic Stroke
- E. Clarke Haley, Jr, Patrick D. Lyden, Karen C. Johnston, Thomas M. Hemmen, and the TNK in Stroke Investigators
Stroke 2005;36:607-612; published online before print as doi:10.1161/01.STR.0000154872.73240.e9
[Abstract]
[Full text]
- Special Reports
A Description of Canadian and United States Physician Reimbursement for Thrombolytic Therapy Administration in Acute Ischemic Stroke
- Dawn Kleindorfer, Michael D. Hill, Daniel Woo, Thomas Tomsick, Arthur Pancioli, Brett Kissela, Andrew M. Demchuk, David Losiewicz, Edward Jauch, Alexander Schneider, Andrew Ringer, Daniel Kanter, and Joseph P. Broderick
Stroke 2005;36:682-687; published online before print as doi:10.1161/01.STR.0000155742.46437.65
[Abstract]
[Full text]
- Articles
Is Heparin Treatment the Optimal Management for Cerebral Venous Thrombosis? Effect of Abciximab, Recombinant Tissue Plasminogen Activator, and Enoxaparin in Experimentally Induced Superior Sagittal Sinus Thrombosis
- Carina Röttger, Katharina Madlener, Matthias Heil, Tibo Gerriets, Maureen Walberer, Tiemo Wessels, Georg Bachmann, Manfred Kaps, and Erwin Stolz
Stroke published February 24, 2005, doi:10.1161/01.STR.0000157663.43209.a2
[Abstract]
- Articles
Sex Differences in Stroke Care and Outcomes. Results From the Registry of the Canadian Stroke Network
- Moira K. Kapral, Jiming Fang, Michael D. Hill, Frank Silver, Janice Richards, Cheryl Jaigobin, and Angela M. Cheung
Stroke published February 24, 2005, doi:10.1161/01.STR.0000157662.09551.e5
[Abstract]
|
|
